SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-11-069602
Filing Date
2011-12-13
Accepted
2011-12-13 16:18:18
Documents
2
Period of Report
2011-10-05
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A v242935_8ka.htm 8-K/A 24153
2 EXHIBIT 10.1 v242935_ex10-1.htm EX-10.1 528998
  Complete submission text file 0001144204-11-069602.txt   554333
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-53127 | Film No.: 111258759
SIC: 4731 Arrangement of Transportation of Freight & Cargo